Basnet Sijan, Dhital Rashmi, Tharu Biswaraj, Ghimire Sushil, Poudel Dilli Ram, Donato Anthony
Department of Internal Medicine, Reading Hospital and Medical Center, West Reading, PA, USA.
Department of Internal Medicine, Trumbull Regional Medical Center, Warren, OH, USA.
J Community Hosp Intern Med Perspect. 2019 Apr 12;9(2):103-107. doi: 10.1080/20009666.2019.1593778. eCollection 2019 Apr.
: Abnormalities in serum potassium levels have been associated with variable mortality risk among hospitalized patients with heart failure (HF). We aim to use a large database study to further characterize risk of mortality, demographic factors, and associated comorbidities among heart failure inpatients. : Our sample population was from the US National Inpatient Sample database from the year 2009-2011. The inclusion criteria used to identify patients was those with a diagnosis of heart failure as per ICD-9 classification. Other demographic factors considered in data collection included income, and cardiac risk factors. Taking these factors into consideration, a univariate association of potassium level and mortality was performed, as well as multivariable logistic regression controlling for demographic factors and associated conditions. : Of the 2,660,609 patients who were discharged with a diagnosis of heart failure during this time period, patients with hypokalemia during hospitalization had increased mortality risk (OR: 1.96, 95% CI: 1.91-2.01) when compared with those with hyperkalemia who had decreased inpatient mortality risk OR: 0.94,95% CI: 0.91-0.96) versus those not coded for potassium abnormalities. This finding was significant even regardless of the etiology of the hypokalemia while the hyperkalemic patients were noted to have no difference or a decreased risk in all subtypes and groups. : Unlike heart failure patients with hyperkalemia, those with hypokalemia are at an increased inpatient mortality risk. Whether our mortality findings translate to longer-term outpatient settings where significantly less monitoring is possible is a matter for further study.
血清钾水平异常与住院心力衰竭(HF)患者的不同死亡风险相关。我们旨在通过一项大型数据库研究,进一步明确心力衰竭住院患者的死亡风险、人口统计学因素及相关合并症。
我们的样本来自2009 - 2011年美国国家住院样本数据库。用于识别患者的纳入标准是根据ICD - 9分类诊断为心力衰竭的患者。数据收集过程中考虑的其他人口统计学因素包括收入和心脏危险因素。考虑到这些因素,我们进行了钾水平与死亡率的单变量关联分析,以及控制人口统计学因素和相关疾病的多变量逻辑回归分析。
在此期间诊断为心力衰竭出院的2,660,609例患者中,住院期间低钾血症患者的死亡风险增加(OR:1.96,95% CI:1.91 - 2.01),而高钾血症患者的住院死亡率风险降低(OR:0.94,95% CI:0.91 - 0.96),与未编码钾异常的患者相比。无论低钾血症的病因如何,这一发现都很显著,而高钾血症患者在所有亚型和组中均无差异或风险降低。
与高钾血症的心力衰竭患者不同,低钾血症患者的住院死亡风险增加。我们的死亡率研究结果是否适用于监测可能显著减少的长期门诊环境,有待进一步研究。